Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -5,319.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 184.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 184.00 |
| Mar 31, 2026 | -748.00 |
| Dec 31, 2025 | -557.00 |
| Sep 30, 2025 | -1,995.00 |
| Jun 30, 2025 | -4,320.00 |
| Mar 31, 2025 | -1,357.00 |
| Dec 31, 2024 | -1,501.00 |
| Sep 30, 2024 | -1,516.00 |
| Jun 30, 2024 | 530.00 |
| Mar 31, 2024 | -247.00 |
| Dec 31, 2023 | -1,050.00 |
| Sep 30, 2023 | 206.00 |
| Jun 30, 2023 | -1,830.00 |
| Mar 31, 2023 | 516.00 |
| Dec 31, 2022 | -4,627.00 |
| Sep 30, 2022 | 2,542.00 |
| Jun 30, 2022 | 2,021.00 |
| Mar 31, 2022 | -344.00 |
| Dec 31, 2021 | 1,670.00 |
| Sep 30, 2021 | 1,609.00 |